NCT07747025Recruiting
Nurse-Led Motivational Interviewing for Blood Pressure Control
The Effect of Nurse-Led Individual and Family-Involved Motivational Interviewing on Blood Pressure Control in Patients With Hypertension: A Three-Arm Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
Hypertension is one of the most important risk factors for cardiovascular morbidity and mortality. Effective hypertension management requires medication adherence, lifestyle modification, regular blood pressure monitoring, and self-management behaviors. Motivational interviewing is a counseling approach that may support behavior change and improve hypertension management. This study aims to evaluate the effects of nurse-led individual motivational interviewing and family-involved motivational interviewing on blood pressure control in patients with hypertension. The study will be conducted as a single-center, three-arm, parallel-group, randomized controlled trial. A total of 180 patients with hypertension will be randomly assigned to one of three groups: usual care, individual motivational interviewing, or family-involved motivational interviewing. Participants in the intervention groups will receive a 6-week nurse-led motivational interviewing program. In the family-involved motivational interviewing group, a family member who supports hypertension management will also participate in the sessions. Data will be collected at baseline, 6 weeks, and 18 weeks. The primary outcome is systolic blood pressure. Secondary outcomes include diastolic blood pressure, hypertension knowledge level, treatment adherence, and hypertension self-efficacy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- First submitted
- 30 Jul 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Kutahya Health Sciences University
- Diseases
- High blood pressure
- NCT number
- NCT07747025
What you commit to
- Study type: Interventional
- Planned participants: 180
- From 1 Aug 2026 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent participation in another structured education program
Other illness
- Advanced cognitive impairment
- Active psychiatric crisis
- History of a serious cardiovascular event within the last 3 months
- Terminal illness
- Serious physical condition that may prevent regular participation in intervention sessions
Who the study is looking for
- Aged 18 years or older
- Diagnosed with hypertension for at least 6 months
- Using antihypertensive medication
- Able to read and understand Turkish
- Conscious and able to communicate
- Providing written informed consent
- Having at least one family member who can support hypertension management and participate in sessions when needed
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Simav Doc. Dr. Ismail Karakuyu State Hospital Coordinator of this site? Confirm its status | Simav | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.